Cargando…
Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759605/ https://www.ncbi.nlm.nih.gov/pubmed/33367968 http://dx.doi.org/10.1186/s40634-020-00323-w |
| _version_ | 1783627140523098112 |
|---|---|
| author | Johnston, Elisha Emani, Chandrakanth Kochan, Andrew Ghebrehawariat, Kidane Tyburski, John Johnston, Michael Rabago, David |
| author_facet | Johnston, Elisha Emani, Chandrakanth Kochan, Andrew Ghebrehawariat, Kidane Tyburski, John Johnston, Michael Rabago, David |
| author_sort | Johnston, Elisha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7759605 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77596052021-01-04 Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro Johnston, Elisha Emani, Chandrakanth Kochan, Andrew Ghebrehawariat, Kidane Tyburski, John Johnston, Michael Rabago, David J Exp Orthop Correction Springer Berlin Heidelberg 2020-12-24 /pmc/articles/PMC7759605/ /pubmed/33367968 http://dx.doi.org/10.1186/s40634-020-00323-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Johnston, Elisha Emani, Chandrakanth Kochan, Andrew Ghebrehawariat, Kidane Tyburski, John Johnston, Michael Rabago, David Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| title | Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| title_full | Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| title_fullStr | Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| title_full_unstemmed | Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| title_short | Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| title_sort | correction to: prolotherapy agent p2g is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759605/ https://www.ncbi.nlm.nih.gov/pubmed/33367968 http://dx.doi.org/10.1186/s40634-020-00323-w |
| work_keys_str_mv | AT johnstonelisha correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro AT emanichandrakanth correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro AT kochanandrew correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro AT ghebrehawariatkidane correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro AT tyburskijohn correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro AT johnstonmichael correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro AT rabagodavid correctiontoprolotherapyagentp2gisassociatedwithupregulationoffibroblastgrowthfactor2geneticexpressioninvitro |